-
C-Telopeptide CAS;162929-64-8 L-Arginine L-α-glutamyl-L-lysyl-L-alanyl-L-histidyl-L-a-aspartylglycylglycyl-
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
Protease-የነቃ ተቀባይ-2 የሚያነቃቃ Peptide CAS 171436-38-7 SLIGRLAMIDE PAR2-AP
Contact me: Email : salesperson66@yeah.net whatsapp: +8619832408762 wickr: fairyqf Skype:+8619832408762 Characteristic: Common name Protease-activated receptor-2 activating peptide English name SLIGRL-NH2 2TFA CAS number 171436-38-7 Density 1.342g/cm3 Molecular formula C 29 H 56 N 10 O 7 Molecular weight 656.81800 Accurate mass 656.43300 PSA 296.74000 LogP 1.79430 Usage: Protease-Activated Receptor-2 Activating Peptide is a protease-activated receptor-2 (PAR-2) ... -
ኒዩሮፔፕቲድ ኤፍ ሲ፡ 99566-27-5 PHE-LEU-PHE-GLN-PRO-GLN-ARG-PHE AMIDE PHE-LEU-PHE-GLN-PRO-GLN-ARG-PHE-NH2 NPFF NEUROPPTIDE FF
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
Myomodulin CAS፡ 110570-93-9 H-Pro-Met-Ser-Met-Leu-Arg-Leu-NH2
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
CAS፡152685-85-3 ሄሞርፊን-7 TYR-PRO-TRP-THR-GLN-ARG-PHE ሄሞርፊን-7
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
ኖሲሴፕቲን CAS፡ 170713-75-4 FGGFTGARKSARKLANQ ORL1 PEPTIDE
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
Arg34-GLP-1(7-37) CAS 204521-68-6 ፖሊፔፕታይድ
Contact me: Email : salesperson66@yeah.net whatsapp: +8619832408762 wickr: fairyqf Skype:+8619832408762 Characteristic: common name Arg34-GLP-1(7-37) English name Arg34-GLP-1(7-37) CAS number 204521-68-6 Density 1.5±0.1g/cm3 Molecular formula C 151 H 228 N 42 O 47 Molecular weight 3383.679 Accurate mass 3381.674316 LogP -5.11 Refractive index 1.664 -
L-Serine, N2- (1-Oxotetradecyl) -L-Lysyl-L-Threonyl-L-Threonyl-L-Lysyl- CAS;1392416-25-9 እ.ኤ.አ
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
CAS 1621694-21-0 TD-1
Contact me: Email : salesperson66@yeah.net whatsapp: +8619832408762 wickr: fairyqf Skype:+8619832408762 Characteristic: common name TD-1 English name TD-1 CAS number 1621694-21-0 Molecular formula C20H16N6O4S2 Molecular weight 468.506 Usage: Hemoglobin modulator TD-1 (TD-1) is a novel allosteric effector of hemoglobin that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling; increases the oxygen affinity of sickle hemoglobin and ... -
Myristoyl Hexapeptide-4 CAS፡ 959610-44-7 ሲምፕፕታይድ 230 ሚሪስቶይል ሄክሳፔፕታይድ-4
Contact me Email : salesexecutive1@yeah.net whatsapp: +8618931626169 wickr: lilywang Usage Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is use... -
የቻይና ሙቅ ሽያጭ CAS 123689-72-5 ሜላኖስታቲን ዲኤም
Contact me: Whatsapp:+8617143104414 Wickr:Zhangcindy123 Email:businessmanager66@yeah.net Synonyms： histidyl-arginyl-alanyl-tryptophyl-phenylalanyl-lysinamide; Melanostatin DM; L-Histidyl-D-arginyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide FAQ 1.Can we get your free samples? Yes, can. Our free sample can be provided for customers test. But the freight for express is on buyer’s account. 2.Can we do printing or label on the bottles? Yes, can. We ... -
ቻይና ትኩስ ሽያጭ CAS 1036207-61-0 Tetrapeptide-30
Contact me: Whatsapp:+8617143104414 Wickr:Zhangcindy123 Email:businessmanager66@yeah.net Synonyms： Tetrapeptide-30; Tetrapeptide-30 (skin lightening peptide); L-Lysine, L-prolyl-L-lysyl-L-α-glutamyl-; (S)-6-Amino-2-((S)-2-((S)-6-amino-2-((S)-pyrrolidine-2-carboxamido)hexanamido)-4-carboxybutanamido)hexanoic acid; Teterapeptide-30; H-Pro-Lys-Glu-Lys-OH; (S)-6-Amino-2-((S)-2-((S)-6-amino-2-((S)-pyrrolidine-2-carboxamido)hexanamido)-4-carboxybutanamido)hexanoic acid[Tetrapeptide-30 Desc...
